BrainsWay Ltd. ( BWAY) - Key Metrics
BWAY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.87 | $0.14 | $0.32 | $0.27 |
| 2026Q1 | $0.81 | $0.12 | $0.06 | $0.02 |
| 2025Q4 | $0.79 | $0.16 | -$0.04 | -$0.04 |
| 2025Q3 | $0.36 | $0.04 | $0.04 | $0.02 |
| 2025Q2 | $0.33 | $0.05 | $0.33 | $0.30 |
BWAY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 28.22 |
| 2026Q1 | 0% | 27.69 |
| 2025Q4 | 0% | 14.77 |
| 2025Q3 | 0% | 47.13 |
| 2025Q2 | 0% | 32.90 |
BWAY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.75% | 0% |
| 2026Q1 | 0.16% | 0% |
| 2025Q4 | -0.44% | 0% |
| 2025Q3 | 0.20% | 0% |
| 2025Q2 | 4.51% | 0% |
BWAY
Price: $11.47
52 week price:
Earnings Per Share: 0.23 USD
P/E Ratio: 63.74
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: Israel
Volume: 22800
Market Capitalization: 490.3 million